Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-046152)

Filing Details

Accession Number:: 0001209191-23-046152
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-08-16 20:53:51
Reporting Period:: 2023-08-16

Accepted Time:: 2023-08-16 20:53:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1806310	Taysha Gene Therapies Inc.	TSHA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1709418	Iii A John Stalfort	C/O Taysha Gene Therapies, Inc. 3000 Pegasus Park Drive, Suite 1430 Dallas TX 75247		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-16	388,889	$0.90	884,290	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2023-08-16	388,889	$0.90	999,381	No	4	P	Direct
Common Stock	Acquisiton	2023-08-16	50,000	$0.00	1,049,381	No	4	G	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Direct
No	4	G	Direct

Footnotes

The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as of October 25, 2018.